United Kingdom, 26th Apr 2025 – Loyal Hound & Co., a UK-based pet life science company, has announced groundbreaking research results demonstrating the significant impact of its age-specific comprehensive formulas in reducing disease rates and promoting stable health throughout a pet’s lifespan. Conducted by Loyal HL Bio LAB—Loyal Hound’s affiliated life science research institute—the study was based on a long-term Randomized Controlled Trial (RCT). It collected data from over 12,000 dogs across 14 clinical partner institutions in eight countries. 40% Reduction in Disease Risk: Evidence-Based Preventive Approach According to the study, dogs that continuously consumed Loyal Hound’s age-specific formulas from the age of one showed a 40.7% lower incidence of diseases compared to control g...

United Kingdom, 26th Apr 2025 – UK-based pet life science company Loyal Hound & Co. has announced the construction of the world’s largest pet longevity research database, having secured life data from one million pets worldwide. The database is built on a vast collection of data sourced from nine countries across Europe, North America, and Asia. It integrates and structures individual-level data for each pet, including genetic information, medical history, dietary and behavioral patterns, caregiver management habits, and environmental factors. A key feature of the database is the inclusion of lifetime health records based on genomics for over 100 dog and cat breeds, making it a precise observational dataset rather than simple statistical information. As such, it is considered a core in...

United Kingdom, 26th Apr 2025 – Loyal Hound & Co., a UK-based pet life science company, has announced groundbreaking research results demonstrating the significant impact of its age-specific comprehensive formulas in reducing disease rates and promoting stable health throughout a pet’s lifespan. Conducted by Loyal HL Bio LAB—Loyal Hound’s affiliated life science research institute—the study was based on a long-term Randomized Controlled Trial (RCT). It collected data from over 12,000 dogs across 14 clinical partner institutions in eight countries. 40% Reduction in Disease Risk: Evidence-Based Preventive Approach According to the study, dogs that continuously consumed Loyal Hound’s age-specific formulas from the age of one showed a 40.7% lower incidence of diseases compared to control g...

United Kingdom, 26th Apr 2025 – UK-based pet life science and pharmaceutical company Loyal Hound & Co. has announced a $2.3 billion (approximately KRW 3.1 trillion) investment to build manufacturing, logistics, and research hubs in China. The decision is viewed as a proactive response to the rapidly growing pet market in East Asia and part of a long-term strategy to mitigate political and institutional risks in the global supply chain. The company plans to establish a 120,000 square meter “Pet Life Science Cluster” within a free trade zone near Shanghai. Key facilities will include a production site for high-performance animal formula products, a research institute dedicated to genomics-based longevity prediction algorithms, and a liaison center to collaborate with veterinary schools a...

United Kingdom, 26th Apr 2025 – The European Union (EU) has designated the pet healthcare industry as a strategic export sector and is launching a full-scale export expansion policy covering 12 high-value items, including animal formulas. This initiative responds to growing global demand for functional pet products made in Europe and is expected to accelerate the international expansion of R&D-driven life science companies. The EU Commission stated, “Animal formulas are a prime example of the shift from treatment-based veterinary prescriptions to preventive daily care,” adding that this category is driving demand as a substitute for pharmaceuticals and is a key sector with strong export competitiveness. High-functionality formulas take root as daily treatment alternativesAccording to a...

Alis Cerrahyan’s memoir The Sound of an Ordinary Life has received multiple awards and recognitions from a wide range of literary and cultural institutions. The book has been honoured for its contribution to personal narrative literature and its nuanced exploration of identity, memory, and emotional growth. Among the awards received are The World’s Best Book Awards – Book of Excellence, the Literary Titan Gold Book Award, and the International Impact Book Awards. In addition, the book has been recognised by the Words Across the Waters Award, the Wordscape Wonders Award, and the Difference Maker Award, among others. These acknowledgments reflect the book’s broad appeal across different readerships and review panels. Critics have consistently highlighted the book’s use of narrative voice and...

Egrya Financial Technology Inc. (“Egrya”), a leading innovator in fintech solutions across emerging markets, today unveiled its 2025 technology roadmap and announced plans to host a global developer conference in Istanbul on October 14–15, 2025. Beyond the major technology updates, a cornerstone of Egrya’s new strategic vision is its commitment to collaborating with universities worldwide to nurture the next generation of AI and blockchain developers. In a world where technology cycles evolve faster than ever, Egrya recognizes that success lies not only in innovation but also in cultivating a global talent pool capable of sustaining technological leadership. The company’s focus on partnering with academic institutions to develop specialized training programs reflects a profound understand...

United Kingdom, 26th Apr 2025 – The European Union (EU) has designated the pet healthcare industry as a strategic export sector and is launching a full-scale export expansion policy covering 12 high-value items, including animal formulas. This initiative responds to growing global demand for functional pet products made in Europe and is expected to accelerate the international expansion of R&D-driven life science companies. The EU Commission stated, “Animal formulas are a prime example of the shift from treatment-based veterinary prescriptions to preventive daily care,” adding that this category is driving demand as a substitute for pharmaceuticals and is a key sector with strong export competitiveness. High-functionality formulas take root as daily treatment alternativesAccording to a...

Miami, FL, United States, 26th Apr 2025 – Killer Whale Ventures has officially launched the Killer Whale Intelligence Platform (KWIP), an artificial intelligence-driven solution developed to support users navigating the cryptocurrency market. The platform offers a suite of digital asset management tools intended to assist a wide range of users, including individual investors, institutions, and portfolio managers. KWIP incorporates machine learning algorithms to monitor market activity and execute trades. It also includes features for developing custom strategies, managing digital asset portfolios, and operating within non-custodial frameworks. The platform is designed to accommodate various user needs by offering both self-directed and professionally managed plans. “KWIP represents a step...

Egrya Financial Technology Inc. (“Egrya”), a leading innovator in fintech solutions across emerging markets, today unveiled its 2025 technology roadmap and announced plans to host a global developer conference in Istanbul on October 14–15, 2025. Beyond the major technology updates, a cornerstone of Egrya’s new strategic vision is its commitment to collaborating with universities worldwide to nurture the next generation of AI and blockchain developers. In a world where technology cycles evolve faster than ever, Egrya recognizes that success lies not only in innovation but also in cultivating a global talent pool capable of sustaining technological leadership. The company’s focus on partnering with academic institutions to develop specialized training programs reflects a profound understand...